| [1] |
苏苗赏，李昌崇．气道高反应性与儿童支气管哮喘[J/CD]．中华妇幼临床医学杂志：电子版，2008，4(3):239-242.
|
| [2] |
Alvarez-Puebla MJ, Olaguibel JM, Almudevar E, et al. Mannitol versus hypertonic saline: safety and efficacy of mannitol and hypertonic saline in sputum induction and bronchial hyperreactivity assessment[J]. Chron Respir Dis, 2015, 12(3):197-203.
|
| [3] |
Perzanowski MS, Yoo Y. Exhaled nitric oxide and airway hyperresponsiveness to adenosine 5′-monophosphate and methacholine in children with asthma[J]. Int Arch Allergy Immunol, 2015, 166(2):107-113.
|
| [4] |
Shim E, Lee E, Yang SI, et al. The association of lung function, bronchial hyperresponsiveness, and exhaled nitric oxide differs between atopic and non-atopic asthma in children[J]. Allergy Asthma Immunol Res, 2015, 7(4):339-345.
|
| [5] |
Roos AB, Mori M, Gronneberg R, et al. Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS[J]. PLoS One, 2014, 9(2):e90018.
|
| [6] |
Yamamoto M, Tochino Y, Chibana K, et al. Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation[J]. Clin Exp Allergy, 2012, 42(5): 760-768.
|
| [7] |
强巴措珍，刘瀚旻．Notch信号通路在哮喘及T淋巴细胞调节中的作用研究进展[J/CD]．中华妇幼临床医学杂志：电子版，2014，10(2):249-255.
|
| [8] |
Malerba M, Radaeli A, Olivini A, et al. The combined impact of exhaled nitric oxide and sputum eosinophils monitoring in asthma treatment: a prospective cohort study[J]. Curr Pharm Des, 2015, 21(32):4752-4562.
|
| [9] |
Alvarez-Puebla MJ, Olaguibel Rivera JM, Almudevar E, et al. Cut off point for exhaled nitric oxide corresponding to 3% sputum eosinophils[J]. J Investig Allergol Clin Immunol, 2015, 25(2):107-111.
|
| [10] |
Sivan Y, Gadish T, Fireman E, et al.The use of exhaled nitric oxide in the diagnosis of asthma in school children[J]. J Pediatr, 2009, 155(2):211-216.
|
| [11] |
Cordeiro D, Rudolphus A, Snoey E, et al. Utility of nitric oxide for the diagnosis of asthma in an allergy clinic population[J]. Allergy Asthma Proc, 2011, 32(1):119-126.
|
| [12] |
Woo SI, Lee JH, Kim H, et al. Utility of fractional exhaled nitric oxide (FeNO) measurements in diagnosing asthma[J]. Respir Med, 2012, 106(8): 1103-1109.
|
| [13] |
Yang S, Park J, Lee YK, et al. Association of longitudinal fractional exhaled nitric oxide measurements with asthma control in atopic children[J]. Respir Med, 2015, 109(5): 572-579.
|
| [14] |
Gemicioglu B, Musellim B, Dogan I, et al. Fractional exhaled nitric oxide (FeNO) in different asthma phenotypes[J]. Allergy Rhinol, 2014, 5(2): e157-e161.
|
| [15] |
Lu M, Wu B, Che D, et al. FeNO and asthma treatment in children: a systematic review and meta-analysis[J]. Medicine, 2015, 94(4):e347-e350.
|
| [16] |
Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications[J]. Am J Respir Crit Care Med, 2011, 184(5): 602-615.
|
| [17] |
Zacharasiewicz A, Wilson N, Lex CH, et al.Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children[J]. Am J Respir Crit care Med, 2005, 171(10): 1077-1082.
|
| [18] |
Ullmann N, Bossley CJ, Fleming L, et al. Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma[J]. Allergy, 2013, 68(3):402-406.
|
| [19] |
Griffin E, Hakansson L, Formgren H, et al.Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosino-phiha[J]. J Allergy Clin Immunol, 1991, 87(2):548-557.
|
| [20] |
Sorva R, Metso T, Turpeinen M, et al. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children[J]. Pediatr Allergy Immanol, 1997, 8(1):45-50.
|
| [21] |
Naseem A, Liaqat J, Zaidi SB, et al.Sputum neutrophilia in severe persistent asthmatics[J]. J Coll Physicians Surg Pak, 2014, 24(6):420-423.
|
| [22] |
Moore WC, Hastie AT, Li X, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis[J]. J Allergy Clin Immunol, 2014, 133(6):1557-1563.
|
| [23] |
Rossall M, Cadden P, Kolsum U, et al. A comparison of the clinical and induced sputum characteristics of early- and late-onset asthma[J]. Lung, 2012, 190(4):459-462.
|
| [24] |
Okunishi K, Peters-Golden M. Leukotrienes and airway inflammation[J]. Biochim Biophys Acta, 2011, 1810(11):1096-1102.
|
| [25] |
Abd El-Motaleb GS, Abou Amer AA, Elawa GM, et al. Study of urinary leukotriene E4 levels in cildren with acute asthma[J]. Int J Gen Med, 2014(7):131-135.
|
| [26] |
Chiu CY, Tsai MH, Yao TC, et al.Urinary LTE4 Levels as a diagnostic marker for IgE-mediated asthma in preschool children: a birth cohort study[J]. PLoS One, 2014, 9(12): e115216.
|
| [27] |
赵海燕，陈宝元，曹洁， 等. 夜间支气管哮喘患者呼吸功能及尿中白三烯E昼夜节律的研究[J]．中华结核和呼吸杂志，2004，27(8):561-562.
|
| [28] |
严炜．孟鲁司特钠联合干扰素α1b治疗小儿喘息性支气管炎的临床疗效[J/CD]．中华妇幼临床医学杂志：电子版，2015，11(5):605-608.
|
| [29] |
Caballero Balanzá S, Aragonés AM, Cerdá Mir JC, et al. Leukotriene B4 and 8-isoprostane in exhaled breath condensate of children with episodic and persistent asthma[J]. J Investig Allergol Clin Immunol, 2010, 20(3): 237-243.
|
| [30] |
Wan GH, Yan DC, Tseng HY, et al. Cysteinyl leukotriene levels correlate with 8-isoprostane levels in exhaled breath condensates of atopic and healthy children[J]. Pediatr Res, 2013, 74(5):584-591.
|
| [31] |
Tomasiak-Lozowska MM, Zietkowski Z, Przeslaw K, et al. Inflammatory markers and acid-base equilibrium in exhaled breath condensate of stable and unstable asthma patients[J]. Int Arch Allergy Immunol, 2012, 159(5):121-129.
|
| [32] |
Loukides S, Kontogianni K, Hillas G, et al. Exhaled breath condensate in asthma: from bench to bedside[J]. Curr Med Chem, 2011, 18(10):1432-1443.
|
| [33] |
Bikov A, Galffy G, Tamasi L, et al. Exhaled breath condensate pH is influenced by respiratory droplet dilution[J]. J Breath Res, 2012, 6(4):046002.
|